SCHEMBL11927552

SCHEMBL11927552

Cc1ccc2c(c1)C(c1ccc(N(c3ccccc3)c3ccccc3)cc1)c1cc(C)ccc1-2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 2/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAOB P27338 3/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
CYP19A1 P11511 1/20 0.33
APP P05067 1/20 0.33
ELANE P08246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11927551 1.00 GAA (0.41) GAAALDH1A1L3MBTL1CYP2C19CYP1A2
SCHEMBL11927550 1.00 GAA (0.41) GAAALDH1A1L3MBTL1CYP2C19CYP1A2
SCHEMBL10111160 0.81 ALDH1A1 (0.48) GAAALDH1A1MAPTKDM4ECYP3A4
SCHEMBL12973434 0.81 MEN1 (0.50) ALDH1A1L3MBTL1CYP2C19CYP1A2MAPT
SCHEMBL22068817 0.80 GAA (0.49) GAAALDH1A1CYP1A2MAPTKDM4E
SCHEMBL24416592 0.77 MAPT (0.37) ALDH1A1L3MBTL1CYP2C19CYP1A2MAPT
SCHEMBL24416591 0.77 MAPT (0.37) ALDH1A1L3MBTL1CYP2C19CYP1A2MAPT
SCHEMBL13050776 0.76 ALDH1A1 (0.45) ALDH1A1L3MBTL1CYP2C19CYP1A2MAPT
SCHEMBL12662974 0.75 L3MBTL1 (0.41) ALDH1A1L3MBTL1CYP2C19CYP1A2MAPT
SCHEMBL24350284 0.75 MAPT (0.38) ALDH1A1L3MBTL1CYP2C19CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2492988-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Sumitomo Chemical Company, Limited (JP) 2012-08-29 EP disclosed
US-20120199825-A1 ORGANIC ELECTROLUMINESCENT DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-09 US disclosed
US-20120199825-A1 ORGANIC ELECTROLUMINESCENT DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-09 US disclosed
US-20110210322-A1 POLYMER COMPOUND CONTAINING NITROGEN-CONTAINING HETEROCYCLIC STRUCTURE, AND COMPOSITION, SOLUTION, THIN FILM AND POLYMER LIGHT-EMITTING ELEMENT EACH CONTAINING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-01 US disclosed
US-20110210322-A1 POLYMER COMPOUND CONTAINING NITROGEN-CONTAINING HETEROCYCLIC STRUCTURE, AND COMPOSITION, SOLUTION, THIN FILM AND POLYMER LIGHT-EMITTING ELEMENT EACH CONTAINING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-01 US disclosed
EP-2336215-A1 POLYMER COMPOUND CONTAINING NITROGEN-CONTAINING HETEROCYCLIC STRUCTURE, AND COMPOSITION, SOLUTION, THIN FILM AND POLYMER LIGHT-EMITTING ELEMENT EACH CONTAINING SAME Sumitomo Chemical Company, Limited (JP) 2011-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110210322-A1 POLYMER COMPOUND CONTAINING NITROGEN-CONTAINING HETEROCYCLIC STRUCTURE, AND COMPOSITION, SOLUTION, THIN FILM AND POLYMER LIGHT-EMITTING ELEMENT EACH CONTAINING SAME H1-10, RNF10, F10 GAA 4767/4885ALDH1A1 2963/4885L3MBTL1 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.